Press Enter to search · ESC to close

Macro US Stocks

HSBC, CATL, Hengrui Diverge as Hong Kong Earnings Test Profit Quality

HSBC’s third-quarter pre-tax profit rose 32% year on year to $9.632 billion, but its Hong Kong-listed shares fell 5.56% to HK$134.30 after stripping a $1.421 billion legal provision cut underlying growth to about 10%. CATL posted 58.58% revenue growth to 165.221 billion yuan while net profit rose 14.54%, and its H-shares slid 11.41% on Oct. 21. Hengrui Medicine gained about 10.9% to HK$49.58 on Oct. 28 after third-quarter net profit jumped 88.92%.

Original source

AI take

The common thread is that headline profit growth is being discounted where quality or margin is questioned: HSBC's gain leaned on a legal provision, and CATL's revenue outpaced profit sharply, which the market read as pressure on profitability. Hengrui's outsized profit jump drew the opposite reaction, suggesting earnings composition, not the topline, is driving re-ratings. The open question is whether this scrutiny of profit quality persists across the rest of Hong Kong's reporting season.

Generated by AI for reference only.

Share

Related News

TREE NEWS share card
Long-press image above → Save to Photos / Share
Pitch us Feedback